Skip to main content

Phase-3 trials find 1-shot chikungunya vaccine safe: Lancet

The first chikungunya vaccine may be on its way with phase 3 trials of a single-shot jab developed by French biotech company Valneva showing the vaccine to be generally safe, well tolerated and provoking an immune response. The study was conducted in the US. Its success will have significant implications for nations like India where chikungunya is endemic.

from Times of India https://ift.tt/1MxiGl9

Comments

Popular posts from this blog

Listen To Indian Muslims' "Mann Ki Baat": Jama Masjid Shahi Imam To PM

Jama Masjid's Shahi Imam Syed Ahmed Bukhari on Friday expressed concerns over the "storm of hatred" in the country, and urged Prime Minister Narendra Modi to listen to the 'Mann Ki Baat' of Muslims. Citing recent incidents like the Nuh riots and the killing of four persons by a railway police jawan on a running train, Ahmed Bukhari suggested in his Friday sermon at the historic mosque that PM Modi and Home Minister Amit Shah hold dialogue with intellectuals from the community. "I have been compelled to speak due to the existing situation in the country. The situation in the country is worrisome and a storm of hatred is posing grave danger to peace in the country," Ahmed Bukhari said. "You say your 'Mann Ki Baat' but you also need to listen to the 'Mann Ki Baat' of Muslims. The Muslims are troubled due to the prevailing conditions and worried about their future," Ahmed Bukhari said, referring to PM Modi's monthly radio pro...